Production (Stage)
Sana Biotechnology, Inc.
SANA
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.53% | 22.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.97% | -15.71% | |||
| Operating Income | 5.97% | 15.71% | |||
| Income Before Tax | -0.65% | 18.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.65% | 18.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.65% | 18.11% | |||
| EBIT | 5.97% | 15.71% | |||
| EBITDA | 6.13% | 16.37% | |||
| EPS Basic | -0.10% | 18.39% | |||
| Normalized Basic EPS | -3.73% | 23.97% | |||
| EPS Diluted | 0.00% | 18.31% | |||
| Normalized Diluted EPS | -3.73% | 23.97% | |||
| Average Basic Shares Outstanding | 0.54% | 0.38% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||